文献速递胸部肿瘤支持与姑息治疗

金雀花碱治疗改善戒烟效果:随机肺癌筛查与多重干预试验

Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial.
PubMed 文献 · J Thorac Oncol · 2022-07-28

在意大利一项单中心随机对照试验中,869名重度吸烟者随机接受金雀花碱加咨询(470人)或仅咨询(399人)。12个月持续戒烟率干预组为32.1%(151人),对照组为7.3%(29人),调整OR为7.2(95%CI 4.6-11.2)。干预组不良事件更常见。

要点

  • 金雀花碱加咨询组12个月持续戒烟率为32.1%,仅咨询组为7.3%。
  • 调整OR为7.2(95%CI 4.6-11.2),支持金雀花碱作为戒烟治疗选择。
  • 干预组不良事件更常见,最常见为胃肠道症状如腹胀、胃炎和便秘。

核心结论

  • 金雀花碱是一种极低成本药物,可作为戒烟的有效治疗选择,并可能改善低剂量CT筛查结局及全因死亡率。

研究设计与样本

  • 单中心随机对照试验,2019年7月至2020年3月纳入869名当前重度烟草使用者,随机分为金雀花碱加咨询组(470人)和仅咨询组(399人)。

主要发现

  • 12个月随访时,干预组持续戒烟率为32.1%(151人),对照组为7.3%(29人)。
  • 持续戒烟的调整OR为7.2(95%CI 4.6-11.2)。
  • 干预组自报不良事件更频繁(196人中399起),对照组为(133人中230起),p<0.01。
  • 最常见不良事件为胃肠道症状,包括腹胀、胃炎和便秘。

关键数值与推荐

  • 主要结局为12个月持续戒烟,通过一氧化碳测量进行生化验证。
  • 干预组持续戒烟率32.1%(151人)vs 对照组7.3%(29人),调整OR 7.2(95%CI 4.6-11.2)。
  • 不良事件干预组196人中399起 vs 对照组133人中230起,p<0.01。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Cytisine, a partial agonist-binding nicotine acetylcholine receptor, is a promising cessation intervention. We conducted a single-center, randomized, controlled trial (RCT) in Italy to assess the efficacy and tolerability of cytisine as a smoking cessation therapy among lung cancer screening participants. METHODS: From July 2019 to March 2020, the Screening and Multiple Intervention on Lung Epidemics RCT enrolled 869 current heavy tobacco users in a low-dose computed tomography screening program, with a randomized comparison of pharmacologic intervention with cytisine plus counseling (N = 470) versus counseling alone (N = 399). The primary outcome was continuous smoking abstinence at 12 months, biochemically verified through carbon monoxide measurement. RESULTS: At the 12-month follow-up, the quit rate was 32.1% (151 participants) in the intervention arm and 7.3% (29 participants) in the control arm. The adjusted OR of continuous abstinence was 7.2 (95% confidence interval: 4.6-11.2). Self-reported adverse events occurred more frequently in the intervention arm (399 events among 196 participants) than in the control arm (230 events among 133 participants, p < 0.01). The most common adverse events were gastrointestinal symptoms, comprising abdominal swelling, gastritis, and constipation. CONCLUSIONS: The efficacy and safety observed in the Screening and Multiple Intervention on Lung Epidemics RCT indicate that cytisine, a very low-cost medication, is a useful treatment option for smoking cessation and a feasible strategy to improve low-dose computed tomography screening outcomes with a potential benefit for all-cause mortality.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Pastorino U, Ladisa V, Trussardo S, et al. Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial. J Thorac Oncol. 2022. PMID: 35908731. doi:10.1016/j.jtho.2022.07.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。